Arrowhead Pharmaceuticals, Inc. Earnings

Arrowhead Pharmaceuticals, Inc.’s revenue jumped +Inf% since last year same period to $542.71Mn in the Q1 2025. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated 117.08% jump in its revenue since last 3-months.

Arrowhead Pharmaceuticals, Inc.’s net profit jumped 393.59% since last year same period to $367.86Mn in the Q1 2025. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated 312.53% jump in its net profits since last 3-months.

Arrowhead Pharmaceuticals, Inc.’s net profit margin jumped NaN% since last year same period to 67.78% in the Q1 2025. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated 197.9% jump in its net profit margins since last 3-months.

Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.46 - a 36.11% jump from last quarter’s estimates.

Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -0.46.

Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) jumped 369.61% since last year same period to 2.75 in the Q1 2025. This indicates that the Arrowhead Pharmaceuticals, Inc. has generated 369.61% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Arrowhead Pharmaceuticals, Inc.’s return on assets (ROA) stands at -0.06.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Arrowhead Pharmaceuticals, Inc.’s return on equity (ROE) stands at -0.26.